Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MORROW GEORGE J −$2.3M Director sold 59% of stake
  2. ABERNETHY MATT −$363K Chief Financial Officer sold 5% of stake
  3. BENEVICH ERIC −$333K Chief Commercial Officer sold 3% of stake
  4. Boyer David W. −$130K Chief Corp. Affairs Officer sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-09 Lippoldt Darin Chief Legal Officer Option exercise · Non-Qualified Stock Option 10b5-1 −10,000 4,965
2026-07-09 Delaet Ingrid Chief Regulatory Officer Option exercise 10b5-1 +8,433 $103.52 $873K 24,658
2026-07-09 Delaet Ingrid Chief Regulatory Officer Sale 10b5-1 −8,433 $178.72 $1.5M 16,225
2026-07-09 Delaet Ingrid Chief Regulatory Officer Option exercise · Non-Qualified Stock Option 10b5-1 −8,433 7,478
2026-07-08 Delaet Ingrid Chief Regulatory Officer Option exercise 10b5-1 +2,737 $103.52 $283K 18,962
2026-07-08 Delaet Ingrid Chief Regulatory Officer Sale 10b5-1 −2,737 $178.54 $489K 16,225
2026-07-08 Delaet Ingrid Chief Regulatory Officer Option exercise · Non-Qualified Stock Option 10b5-1 −2,737 15,911
2026-07-07 Delaet Ingrid Chief Regulatory Officer Option exercise 10b5-1 +3,401 $103.52 $352K 19,626
2026-07-07 Delaet Ingrid Chief Regulatory Officer Sale 10b5-1 −3,401 $178.57 $607K 16,225
2026-07-07 Delaet Ingrid Chief Regulatory Officer Option exercise · Non-Qualified Stock Option 10b5-1 −3,401 18,648
2026-06-29 Lippoldt Darin Chief Legal Officer Option exercise 10b5-1 +8,110 $81.49 $661K 62,839
2026-06-29 Lippoldt Darin Chief Legal Officer Sale 10b5-1 −8,110 $170.03 $1.4M 54,729
2026-06-29 Lippoldt Darin Chief Legal Officer Option exercise 10b5-1 +1,690 $81.49 $138K 56,419
2026-06-29 Lippoldt Darin Chief Legal Officer Sale 10b5-1 −1,690 $170.81 $289K 54,729
2026-06-29 Lippoldt Darin Chief Legal Officer Option exercise · Non-Qualified Stock Option 10b5-1 −8,110 16,655
2026-06-29 Lippoldt Darin Chief Legal Officer Option exercise · Non-Qualified Stock Option 10b5-1 −1,690 14,965
2026-06-26 Lippoldt Darin Chief Legal Officer Option exercise 10b5-1 +200 $81.49 $16K 54,929
2026-06-26 Lippoldt Darin Chief Legal Officer Sale 10b5-1 −200 $169.57 $34K 54,729
2026-06-26 Lippoldt Darin Chief Legal Officer Option exercise · Non-Qualified Stock Option 10b5-1 −200 24,765
2026-06-05 Onyia Jude Chief Scientific Officer Gift −2,441 23,405

Page 4 of 37 · 740 trades